Delivery Order HHSN272201100016I-75N93018F00015
- This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) as a Delivery Order. The contract is for "IN VITRO ASSESSMENTS FOR ANTIMICROBIAL ACTIVITY" and is part of the larger "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery, Indefinite Quantity (IDIQ) contract. The contract has a ceiling value of $1,277,140.50 and a...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $499,760.00 firm fixed-price delivery order contract to the University of Alabama at Birmingham (UAB) for in vitro assessments of antimicrobial activity. This contract is under the parent "In Vitro Assessments of Antimicrobial Activity (IVAAA)" Indefinite Delivery Contract (IDC). UAB, a non-profit, state-controlled institution of higher...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) to provide in vitro assessments for antimicrobial activity. The contract, valued at $12,178, is a delivery order under the larger "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery Contract (IDC) vehicle. The award has a completion date of November 14, 2013,...
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to the University of Alabama at Birmingham (UAB) on August 22, 2017. The contract has a potential value of $845,508.52 and a completion date of September 15, 2018. The contract is for in vitro assessment for antimicrobial activity and a comprehensive viral screening panel. This delivery order is...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the University of Alabama at Birmingham (UAB). The $2,171,785.57 delivery order supports NIAID protocol #07-0012, a study to enroll male participants and evaluate a treatment for an unspecified infectious disease. The contract does not have a set-aside designation. The contract has two subcontractors: the University of Southern...
- This is a Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) for in vitro assessment of antimicrobial activity. The contract has a ceiling value of $1,282,905.51 and was awarded on September 17, 2012, with a completion date of September 16, 2013. The contract is under a larger Indefinite Delivery Contract (IDC) vehicle named "In Vitro Antimicrobial...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Alabama at Birmingham (UAB) to provide a "SUPPLEMENT TO COMPREHENSIVE PANEL FOR VIRUSES". The $26,500.00 Firm Fixed Price contract was awarded on March 24, 2015 as a Delivery Order under the "In Vitro Antimicrobial Assessments 2011-2018" Indefinite Delivery Contract (IDC). The contract has no set-aside designation. As a leading...
- This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Alabama at Birmingham (UAB) under the In Vitro Antimicrobial Assessments 2011-2018 IDIQ contract. The contract, which does not have a set-aside designation, is for $216,637.50 and covers in vitro antimicrobial assessments under Task B07. UAB, a leading public research university and academic medical center,...
- This contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to the University of Alabama at Birmingham (UAB), an internationally renowned research university and academic medical center. The contract, valued at $616,373.16, is a Firm Fixed Price Delivery Order under the "In Vitro Assessments of Antimicrobial Activity (IVAAA)" master IDIQ contract. The objective is to determine the...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $978,590.76 Firm Fixed Price Delivery Order to the University of Alabama at Birmingham (UAB) on August 15, 2014 for a "Comprehensive Panel for Viruses" requirement. This Delivery Order was placed under NIAID's In Vitro Antimicrobial Assessments 2011-2018 Indefinite Delivery, Indefinite Quantity (IDIQ) contract and had a completion date of September 29, 2015. UAB, a public research university and academic...
- In Vitro Antimicrobial Assessments 2011-2018Master IDIQ
- HHSN272201100016IIndefinite Delivery Contract
- HHSN272201100016I-75N93018F00015Delivery Order
This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to the University of Alabama at Birmingham (UAB) for $380,755.17. The contract is a delivery order under a larger indefinite delivery contract titled "In Vitro Antimicrobial Assessments 2011-2018" and involves in vitro assessment for antimicrobial activity. The contract is for a firm fixed price and does not have a set-aside designation. As a subcontractor, Family Health International (FHI 360) will serve as the Operations Coordinating Center and provide a Protocol Specialist and Research Assistant to support the protocol development and implementation. FHI 360 is a nonprofit organization that has previously supported federal agencies like the Centers for Disease Control and Prevention, Department of State, and Department of Education through prime and sub-contracts in areas such as public health, humanitarian assistance, and education.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
IN VITRO ASSESSMENTS FOR ANTIMICROBIAL ACTIVITY | NIAID-DMID-NIHAI2009066 | Department of Health and Human Services National Institutes of Health | Award Notice 1/1 | 9/2/09, 11:39 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $6.0k | 3/13/19 | |
| P00002 | Funding Only Action | ($10k) | 5/31/18 | |
| Not listed | Not listed | $329.9k | 5/2/18 |